HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

John C Byrd Selected Research

John C Byrd Research Topics

Disease

123B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2015 - 02/2002
78Neoplasms (Cancer)
09/2015 - 02/2002
35Leukemia
09/2015 - 02/2002
29Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2015 - 01/2004
17Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2015 - 02/2002
17Lymphoma (Lymphomas)
04/2015 - 08/2003
11Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2015 - 01/2009
8Hematologic Neoplasms (Hematological Malignancy)
01/2015 - 09/2003
8BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2014 - 05/2005
8Multiple Myeloma
02/2014 - 05/2008
7Infection
01/2015 - 04/2002
7Tumor Lysis Syndrome
12/2014 - 08/2003
7Chromosome Aberrations (Chromosome Abnormalities)
12/2014 - 01/2003
7Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2013 - 04/2008
6Graft vs Host Disease (Graft-Versus-Host Disease)
11/2014 - 04/2005
6Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2013 - 09/2007
5Diarrhea
07/2014 - 05/2010
5Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2012 - 04/2008
5B-Cell Lymphoma (Lymphoma, B Cell)
03/2009 - 08/2003
4Neutropenia
12/2014 - 05/2010
4Fatigue
07/2014 - 05/2010
4Fever (Fevers)
07/2014 - 09/2002
4Residual Neoplasm
03/2014 - 03/2004
3Agammaglobulinemia (Hypogammaglobulinemia)
07/2015 - 04/2002
3Thrombocytopenia (Thrombopenia)
12/2014 - 04/2010
3Nausea
07/2014 - 05/2010
3Lymphatic Diseases (Lymphadenopathy)
05/2014 - 01/2009
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2013 - 02/2004
3Disease Progression
03/2010 - 08/2004
2Opportunistic Infections (Opportunistic Infection)
04/2015 - 12/2005
2Hairy Cell Leukemia
01/2015 - 03/2012
2Breast Neoplasms (Breast Cancer)
01/2015 - 05/2013
2Burkitt Lymphoma (Burkitt's Lymphoma)
10/2013 - 06/2011

Drug/Important Bio-Agent (IBA)

37rituximab (Mabthera)FDA Link
01/2015 - 02/2002
27fludarabineIBA
11/2015 - 02/2002
27flavopiridolIBA
05/2015 - 06/2005
15Phosphotransferases (Kinase)IBA
02/2015 - 05/2005
13lenalidomide (CC 5013)FDA Link
04/2015 - 05/2008
10Histones (Histone)IBA
04/2015 - 07/2003
9Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2015 - 12/2005
9CyclinsIBA
02/2015 - 01/2007
8fingolimod (FTY720)FDA Link
09/2015 - 09/2007
8Immunoglobulins (Immunoglobulin)IBA
04/2015 - 02/2004
8Pentostatin (Nipent)FDA LinkGeneric
01/2015 - 04/2005
8bortezomib (Velcade)FDA Link
06/2014 - 09/2006
8alemtuzumab (Campath)FDA Link
12/2013 - 07/2003
8DNA (Deoxyribonucleic Acid)IBA
01/2013 - 02/2005
8decitabine (5-aza-2'-deoxycytidine)FDA Link
01/2013 - 07/2005
7Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2015 - 06/2011
7AntibodiesIBA
06/2015 - 08/2007
7AntigensIBA
02/2014 - 09/2003
6Cytarabine (Cytosar-U)FDA LinkGeneric
06/2015 - 01/2003
6imatinib (Gleevec)FDA Link
12/2014 - 05/2005
5MicroRNAs (MicroRNA)IBA
09/2015 - 06/2009
5Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
07/2014 - 08/2004
5Proteins (Proteins, Gene)IBA
05/2013 - 01/2003
4milatuzumabIBA
06/2015 - 04/2011
4RNA (Ribonucleic Acid)IBA
04/2015 - 06/2009
4Agammaglobulinaemia tyrosine kinase (Bruton's tyrosine kinase)IBA
01/2015 - 02/2014
4Phosphatidylinositols (Phosphatidylinositol)IBA
05/2014 - 01/2009
4Interleukin-2 (IL2)IBA
01/2010 - 09/2004
4Histone Deacetylases (Histone Deacetylase)IBA
02/2005 - 07/2003
3Proteasome Endopeptidase Complex (Proteasome)IBA
10/2015 - 01/2009
3ofatumumabFDA Link
08/2015 - 03/2013
3Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
06/2015 - 06/2008
3GTI2040IBA
06/2015 - 06/2008
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
12/2014 - 09/2010
3Cyclin D1IBA
02/2014 - 06/2010
3OligonucleotidesIBA
01/2013 - 06/2009
3death-associated protein kinaseIBA
01/2013 - 06/2007
3silvestrolIBA
01/2013 - 05/2009
3interleukin-21 (interleukin 21)IBA
10/2012 - 05/2008
3Immunoglobulin G (IgG)IBA
04/2012 - 02/2004
3Protein Kinases (Protein Kinase)IBA
06/2011 - 09/2006
3Monoclonal AntibodiesIBA
11/2010 - 07/2003
3NF-kappa B (NF-kB)IBA
07/2010 - 02/2008
3oblimersen (G3139)IBA
01/2010 - 01/2003
3Messenger RNA (mRNA)IBA
01/2010 - 08/2007
3Complement System Proteins (Complement)IBA
01/2008 - 02/2002
2carfilzomibIBA
10/2015 - 05/2013
2OligodeoxyribonucleotidesIBA
06/2015 - 02/2010
2monoclonal antibody IMMU-106IBA
06/2015 - 04/2012
2Biological Markers (Surrogate Marker)IBA
05/2015 - 01/2010
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2014 - 05/2014
2NucleotidesIBA
07/2014 - 01/2008
2ChromatinIBA
03/2014 - 01/2011
2Small Interfering RNA (siRNA)IBA
11/2013 - 04/2007
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
09/2013 - 01/2013
2Transferrin (beta 2 Transferrin)IBA
05/2013 - 02/2010
2Liposomes (Liposome)IBA
01/2013 - 04/2008
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2013 - 09/2002
2Thalidomide (Thalomid)FDA Link
12/2012 - 01/2010

Therapy/Procedure

18Drug Therapy (Chemotherapy)
11/2015 - 02/2002
10Therapeutics
01/2015 - 07/2003
8Heterologous Transplantation (Xenotransplantation)
06/2015 - 10/2007
5Renal Dialysis (Hemodialysis)
05/2015 - 11/2007
4Transplants (Transplant)
08/2013 - 01/2006
4Immunotherapy
04/2012 - 09/2004
3Aftercare (After-Treatment)
01/2009 - 02/2002
2Hematopoietic Stem Cell Transplantation
11/2014 - 06/2014